NO20005223L - Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen - Google Patents

Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen

Info

Publication number
NO20005223L
NO20005223L NO20005223A NO20005223A NO20005223L NO 20005223 L NO20005223 L NO 20005223L NO 20005223 A NO20005223 A NO 20005223A NO 20005223 A NO20005223 A NO 20005223A NO 20005223 L NO20005223 L NO 20005223L
Authority
NO
Norway
Prior art keywords
inflammatory bowel
bowel disease
composition
acetylglucosamine
colon
Prior art date
Application number
NO20005223A
Other languages
English (en)
Other versions
NO20005223D0 (no
Inventor
Simon Murch
Ian W French
Original Assignee
Glucogenics Pharmaceuticals In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA1999/000218 external-priority patent/WO1999053929A1/en
Application filed by Glucogenics Pharmaceuticals In filed Critical Glucogenics Pharmaceuticals In
Publication of NO20005223D0 publication Critical patent/NO20005223D0/no
Publication of NO20005223L publication Critical patent/NO20005223L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Oppfinnelsen angår en ny sammensetning og en ny fremgangsmåte til å behandle inflammatorisk tarmsykdom (IBD). Mer spesielt angår denne oppfinnelsen en ny sammensetning som inneholder N-acetylglukosamin (NAG) som et aktivt IBD- behandlende middel og en farmasøytisk egnet bærer, og en fremgangsmåte til å administrere sammensetningen til colon for å behandle IBD hos en person som lider av IBD. En sammensetning for å behandle inflammatorisk tarmsykdom hos en pasient som lider av inflammatorisk tarmsykdom omfatter: (a) en terapeutisk mengde av N- acetylglukosamin; og (b) en farmasøytisk akseptabel bærer, tilpasset til å bli administrert til colon hos nevnte pasient.
NO20005223A 1998-04-17 2000-10-17 Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen NO20005223L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (en) 1998-04-17 1998-04-17 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
PCT/CA1999/000218 WO1999053929A1 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Publications (2)

Publication Number Publication Date
NO20005223D0 NO20005223D0 (no) 2000-10-17
NO20005223L true NO20005223L (no) 2000-11-20

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005223A NO20005223L (no) 1998-04-17 2000-10-17 Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen

Country Status (8)

Country Link
EP (1) EP1071432A1 (no)
JP (1) JP2002512195A (no)
CA (1) CA2234936C (no)
CZ (1) CZ20003846A3 (no)
HU (1) HUP0101514A3 (no)
IL (1) IL139072A0 (no)
NO (1) NO20005223L (no)
PL (1) PL343634A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ599605A (en) 2007-02-19 2013-11-29 Marinepolymer Tech Inc Hemostatic compositions and therapeutic regimens
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
BR112012025844A2 (pt) 2010-04-15 2017-07-18 Marine Polymer Tech Inc uso de nanofibras snag
ES2712098T3 (es) 2011-04-15 2019-05-09 Marine Polymer Tech Inc Tratamiento de infecciones por VHS con nanofibras de poli-N-acetilglucosamina
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
ES2786312T3 (es) * 2014-11-26 2020-10-09 Evonik Operations Gmbh Composición farmacéutica o nutracéutica con resistencia contra la influencia de etanol
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
EP1071432A1 (en) 2001-01-31
HUP0101514A2 (hu) 2001-11-28
CA2234936A1 (en) 1999-10-17
PL343634A1 (en) 2001-08-27
NO20005223D0 (no) 2000-10-17
CZ20003846A3 (cs) 2002-03-13
HUP0101514A3 (en) 2003-07-28
JP2002512195A (ja) 2002-04-23
CA2234936C (en) 2004-06-29
IL139072A0 (en) 2001-11-25

Similar Documents

Publication Publication Date Title
NO20052348L (no) Behandling av hemoragisk sjokk
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
NO20033617L (no) Fremgangsmate for behandling av diabetes mellitus
MY120279A (en) Use of a celecoxib composition for fast pain relief
HK1070575A1 (en) Use of botulinum toxin for treating cardiovasculardiseases
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
TW200510349A (en) Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
NO20003051L (no) Metode for administrering av AspB28-humant insulin
SG148850A1 (en) Methods of treating vascular disease
WO2003105763B1 (en) PREVENTION AND / OR TREATMENT OF INFLAMMATORY ENTERIC DISEASE USING YY PEPTIDES OR YY PEPTIDES ANTAGONISTS
HK1086186A1 (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
EP0957925A4 (en) TREATMENT OF OSTEOARTHRITIS BY ADMINISTRATION OF POLY-N-ACETYL-D-GLUCOSAMINE
ATE305469T1 (de) Sulfonsäure- oder sulfonylamino-n-(heteroaralkyl)-azaheterozyklyl midverbindungen
NO20024924L (no) Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
BR0008443A (pt) Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
EP1447090B8 (de) Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
NO984974L (no) Middel som forbedrer pulmonar sirkulasjon
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
WO2003024394A3 (en) Method of treating benign prostatic hyperplasia and other beingn porstate conditions
RU2006138043A (ru) Способ лечения инсульта с применением введения дефибриногенизирующих средств для достижения специфического характера дефибриногенизации
UA38056A (uk) Спосіб прогнозування та контролю ефективності лікування гіпертонічної хвороби

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application